These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19542461)
1. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. Raby AC; Le Bouder E; Colmont C; Davies J; Richards P; Coles B; George CH; Jones SA; Brennan P; Topley N; Labéta MO J Immunol; 2009 Jul; 183(1):506-17. PubMed ID: 19542461 [TBL] [Abstract][Full Text] [Related]
2. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. LeBouder E; Rey-Nores JE; Rushmere NK; Grigorov M; Lawn SD; Affolter M; Griffin GE; Ferrara P; Schiffrin EJ; Morgan BP; Labéta MO J Immunol; 2003 Dec; 171(12):6680-9. PubMed ID: 14662871 [TBL] [Abstract][Full Text] [Related]
3. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Raby AC; Holst B; Le Bouder E; Diaz C; Ferran E; Conraux L; Guillemot JC; Coles B; Kift-Morgan A; Colmont CS; Szakmany T; Ferrara P; Hall JE; Topley N; Labéta MO Sci Transl Med; 2013 May; 5(185):185ra64. PubMed ID: 23677593 [TBL] [Abstract][Full Text] [Related]
4. Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production. Langjahr P; Díaz-Jiménez D; De la Fuente M; Rubio E; Golenbock D; Bronfman FC; Quera R; González MJ; Hermoso MA PLoS One; 2014; 9(12):e104624. PubMed ID: 25531754 [TBL] [Abstract][Full Text] [Related]
5. TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo. Zivkovic A; Sharif O; Stich K; Doninger B; Biaggio M; Colinge J; Bilban M; Mesteri I; Hazemi P; Lemmens-Gruber R; Knapp S J Immunol; 2011 Feb; 186(3):1608-17. PubMed ID: 21178007 [TBL] [Abstract][Full Text] [Related]
6. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. Knapp S; von Aulock S; Leendertse M; Haslinger I; Draing C; Golenbock DT; van der Poll T J Immunol; 2008 Mar; 180(5):3478-84. PubMed ID: 18292574 [TBL] [Abstract][Full Text] [Related]
7. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages. Hong SW; Baik JE; Kang SS; Yun CH; Seo DG; Han SH Mol Immunol; 2014 Feb; 57(2):284-91. PubMed ID: 24216318 [TBL] [Abstract][Full Text] [Related]
8. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. Dulay AT; Buhimschi CS; Zhao G; Oliver EA; Mbele A; Jing S; Buhimschi IA J Immunol; 2009 Jun; 182(11):7244-53. PubMed ID: 19454721 [TBL] [Abstract][Full Text] [Related]
13. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. Melmed G; Thomas LS; Lee N; Tesfay SY; Lukasek K; Michelsen KS; Zhou Y; Hu B; Arditi M; Abreu MT J Immunol; 2003 Feb; 170(3):1406-15. PubMed ID: 12538701 [TBL] [Abstract][Full Text] [Related]
14. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. Henrick BM; Nag K; Yao XD; Drannik AG; Aldrovandi GM; Rosenthal KL PLoS One; 2012; 7(7):e40138. PubMed ID: 22792230 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620 [TBL] [Abstract][Full Text] [Related]
16. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. Strunk T; Power Coombs MR; Currie AJ; Richmond P; Golenbock DT; Stoler-Barak L; Gallington LC; Otto M; Burgner D; Levy O PLoS One; 2010 Apr; 5(4):e10111. PubMed ID: 20404927 [TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide. Hoppstädter J; Dembek A; Linnenberger R; Dahlem C; Barghash A; Fecher-Trost C; Fuhrmann G; Koch M; Kraegeloh A; Huwer H; Kiemer AK Front Immunol; 2019; 10():1634. PubMed ID: 31396208 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis. Talreja D; Singh PK; Kumar A Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1719-32. PubMed ID: 25678692 [TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. Erridge C; Kennedy S; Spickett CM; Webb DJ J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343 [TBL] [Abstract][Full Text] [Related]
20. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. Bowdish DM; Sakamoto K; Kim MJ; Kroos M; Mukhopadhyay S; Leifer CA; Tryggvason K; Gordon S; Russell DG PLoS Pathog; 2009 Jun; 5(6):e1000474. PubMed ID: 19521507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]